SCHEMBL9510405

SCHEMBL9510405

CCCc1c(OCCCCCC(=O)c2ccc(OC)c(OC)c2)ccc(C(=O)O)c1O

nearest known ligand 0.57

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.56
CYSLTR2 Q9NS75 4/20 0.53
CYSLTR1 Q9Y271 4/20 0.53
THRA P10827 1/20 0.53
THRB P10828 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9558415 0.92 GRM2 (0.55) GRM2CYSLTR2CYSLTR1
SCHEMBL9558691 0.91 GRM2 (0.56) GRM2CYSLTR2CYSLTR1
SCHEMBL9579649 0.91 THRA (0.52) GRM2CYSLTR2CYSLTR1THRATHRB
SCHEMBL9510563 0.89 GRM2 (0.57) GRM2CYSLTR2CYSLTR1
SCHEMBL9508793 0.89 GRM2 (0.57) GRM2CYSLTR2CYSLTR1
SCHEMBL9558314 0.86 GRM2 (0.57) GRM2CYSLTR2CYSLTR1
SCHEMBL9558405 0.86 GRM2 (0.57) GRM2CYSLTR2CYSLTR1
SCHEMBL9557998 0.86 GRM2 (0.57) GRM2CYSLTR2CYSLTR1
SCHEMBL9506933 0.86 CYSLTR2 (0.52) GRM2CYSLTR2CYSLTR1
SCHEMBL9509067 0.85 CYSLTR2 (0.49) GRM2CYSLTR2CYSLTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0310126-B1 DERIVATIVES OF PYROCATECHOL-CARBOXYLIC ACID, THEIR PREPARATION AND USE AS ACTIVE INGREDIENTS IN MEDICINES F. HOFFMANN-LA ROCHE AG (CH) 1993-08-18 EP disclosed
US-5191108-A Lipoxygenase inhibitors, antiinflammatory agents HOFFMANN-LA ROCHE INC. (US) 1993-03-02 US disclosed
US-5025036-A Antiinflammatory agents, gastrointestinal, cardiovascular and skin disorders HOFFMANN-LA ROCHE INC. (US) 1991-06-18 US disclosed
EP-0310126-A2 Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines F. HOFFMANN-LA ROCHE AG (CH) 1989-04-05 EP disclosed